ClearPoint Neuro (CLPT) Gets FDA's Nod for New Software
https://www.zacks.com/stock/news/2231836/clearpoint-neuro-clpt-gets-fda-s-nod-for-new-software?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2231836
Feb 26, 2024 - ClearPoint Neuro's (CLPT) receipt of the FDA's latest approval is likely to provide fast, peri-procedural segmentation of the cortical structures of the brain.
0
Bruker's (BRKR) New Launches Drive Growth Amid FX Woes
https://www.zacks.com/stock/news/2231831/bruker-s-brkr-new-launches-drive-growth-amid-fx-woes?cid=CS-ZC-FT-analyst_blog|zer_report_update-2231831
Feb 26, 2024 - Bruker's (BRKR) revenues continue to be driven by the strength of end markets, including academic and government, and industrial.
0
Philips' (PHG) New Innovation to Boost Radiation-Free Imaging
https://www.zacks.com/stock/news/2231630/philips-phg-new-innovation-to-boost-radiation-free-imaging?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2231630
Feb 26, 2024 - Philips (PHG) announces its latest LumiGuide imaging technology, which is likely to pave the way for new radiation-free procedures. It will prove beneficial for complex aortic surgeries.
0
ICON (ICLR) Q4 Earnings Surpass Estimates, Margins Expand
https://www.zacks.com/stock/news/2230458/icon-iclr-q4-earnings-surpass-estimates-margins-expand?cid=CS-ZC-FT-analyst_blog|earnings_article-2230458
Feb 22, 2024 - ICON's (ICLR) solid performance in the fourth quarter reflects continued market leadership across customer segments it serves.
0
Better Therapeutics' (BTTX) CBT Gains FDA's Breakthrough Status
https://www.zacks.com/stock/news/2230299/better-therapeutics-bttx-cbt-gains-fda-s-breakthrough-status?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2230299
Feb 22, 2024 - Better Therapeutics' (BTTX) novel CBT platform attains the FDA's breakthrough device designation to improve patient care in the treatment of liver and metabolic diseases.
0
Why Cardinal Health (CAH) is a Top Momentum Stock for the Long-Term
https://www.zacks.com/stock/news/2230219/why-cardinal-health-cah-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2230219
Feb 22, 2024 - Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
0
Here's Why You Should Retain Align Technology (ALGN) Stock Now
https://www.zacks.com/stock/news/2229514/here-s-why-you-should-retain-align-technology-algn-stock-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2229514
Feb 21, 2024 - Investors are optimistic about Align Technology (ALGN) on continued geographic expansion.
0
Charles River (CRL) Gains From CRADL Amid Soft Market Scenario
https://www.zacks.com/stock/news/2229453/charles-river-crl-gains-from-cradl-amid-soft-market-scenario?cid=CS-ZC-FT-analyst_blog|zer_report_update-2229453
Feb 21, 2024 - Within DSA, Charles River (CRL) is currently the largest provider of outsourced drug discovery, non-clinical development and regulated safety testing services worldwide.
0
Sight Sciences (SGHT) to Expand in Europe With New Launch
https://www.zacks.com/stock/news/2229444/sight-sciences-sght-to-expand-in-europe-with-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2229444
Feb 21, 2024 - By tapping into the European market, Sight Sciences (SGHT) aims to capitalize on the growing demand for advanced eye care technologies.
0
Medtronic (MDT) Q3 Earnings Beat Estimates, 2024 View Up
https://www.zacks.com/stock/news/2228769/medtronic-mdt-q3-earnings-beat-estimates-2024-view-up?cid=CS-ZC-FT-analyst_blog|earnings_article-2228769
Feb 20, 2024 - Medtronic's (MDT) third-quarter organic growth reflects broad strength across businesses and geographies.
0